PCT LTD has Filed a Joint Patent Application with NanoGas Technologies’
PCT LTD (PCTL) has announced a patent pending technology combining electrochemically activated solutions with nanobubble dispersions to enhance biocidal properties. This innovation targets corrosive bacteria in the oilfield and aims to improve oil recovery from fractured reservoirs. Currently undergoing field trials in Southwest Missouri, Oklahoma, and Texas, the company plans to validate this technology further. A detailed report is set for release on November 17, 2021. CEO Gary Grieco highlighted the extensive lab and field testing conducted over nine months to support this patent filing.
- Introduction of patent pending technology enhancing biocidal properties using nanobubbles.
- Potential for improved oil recovery demonstrated in lab studies.
- Ongoing field trials showing positive results in multiple regions.
- Plans for broader marketing of technology to the oil industry.
- None.
(NGT) and
In addition, the application of PCT’s Catholyte-Free™ infused with NGT’s nitrogen nanobubbles has been shown in laboratory studies to significantly improve oil recovery from porous or naturally fractured reservoirs using the combined surface energy and mechanical properties inherent to these nanobubble dispersions. Field trials being conducted in
“We have been working for over nine months in laboratory and field testing to gather the necessary data and information to file this patent. We will post an in-depth report on the value of this new process to the markets, on our website on
About
Forward-Looking Statements:
This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."
Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: PCTL's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCTL to execute its business plan; the anticipated results of business contracts with regard to revenue; and any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCTL makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20211105005820/en/
Investor Relations Contact
(760) 621-0062
Mike@MountaintopMedia.net
or
IR@para-con.com
www.para-con.com
www.pctcorphealth.com
Twitter: https://mobile.twitter.com/PCTL_
Source:
FAQ
What is the new technology announced by PCT LTD (PCTL)?
Where are the field trials for PCT LTD's new technology taking place?
When will PCT LTD (PCTL) release a detailed report on their new technology?